BioAsia 2024: Redefining the Future of Life Sciences
BioAsia, the renowned annual event in the life sciences sector, is gearing up to set a new standard with its 21st edition, BioAsia 2024. Scheduled from February 26 to 28, 2024, this transformative event carries the overarching theme of “Data and AI: Redefining Possibilities,” and is poised to reshape the future of life sciences.
BioAsia 2024 has lined up a galaxy of visionary keynote speakers who will share their expertise and insights. These esteemed leaders include Dave Ricks, CEO of Eli Lilly, Dr Chris Boerner, Incoming CEO of Bristol Myers Squibb (BMS), Geoff Martha, Chairman and CEO of Medtronic, Christophe Weber, CEO of Takeda, and Nobel Laureate Professor Gregg Semenza.
Under the leadership of Dave Ricks, the market valuation of Eli Lilly has soared from around USD 80 billion in 2017 to USD 310 billion in 2023. Dr Chris Boerner, a distinguished figure in the pharmaceutical industry, is set to lead Bristol-Myers Squibb into the future. BMS stands as one of the world’s largest pharmaceutical companies.
Geoff Martha, a visionary leader, is leading Medtronic towards groundbreaking innovations. Medtronic, with 95,000 employees, delivers pioneering technology solutions to improve the lives of people worldwide. Christophe Weber brings his global pharmaceutical expertise to the BioAsia platform as the CEO of Takeda, which expanded its global presence through the USD 62 billion acquisition of Shire.
Professor Gregg Semenza, a Nobel laureate, is celebrated for his groundbreaking work on oxygen sensing. His discovery of the Hypoxia-Inducible Factor 1 (HIF) pathway has paved the way for innovative therapies and advanced our understanding of conditions like cancer and anaemia.
This luminary lineup of keynote speakers makes BioAsia 2024 an unparalleled platform for networking and knowledge sharing. The event has garnered global recognition as a premier life sciences event, underscoring Telangana’s position as a life sciences powerhouse.
Organized in partnership with EY India as the Knowledge Partner, BioAsia 2024 aims to foster transformative ideas and partnerships. With its focus on data, AI, and life sciences, the event promises to redefine the future of healthcare and research. BioAsia’s vibrant ecosystem fosters collaborations, discussions, and partnerships that drive innovation and shape the future of the industry.
Sources: BioAsia 2024, EY India
